Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
about
"TRP inflammation" relationship in cardiovascular systemFibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunctionImmunosuppression With FTY720 Reverses Cardiac Dysfunction in Hypomorphic ApoE Mice Deficient in SR-BI Expression That Survive Myocardial Infarction Caused by Coronary Atherosclerosis.Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.Revisiting Cardiac Cellular Composition.Tripartite motif 32 prevents pathological cardiac hypertrophyTriptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy.Diabetic Cardiomyopathy: An Immunometabolic Perspective.Cardiac Remodeling: Concepts, Clinical Impact, Pathophysiological Mechanisms and Pharmacologic Treatment.Anti-fibrotic actions of relaxin.Role of bone marrow-derived CD11c+ dendritic cells in systolic overload-induced left ventricular inflammation, fibrosis and hypertrophy.T-cell immunity in myocardial inflammation: pathogenic role and therapeutic manipulation.The Neutrophil-to-Lymphocyte Ratio Predicts All-Cause Mortality in Patients with Implantable Cardioverter Defibrillators.An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy.Role of Inflammation in Heart Failure.Iron Metabolism and the Inflammatory Response.CD28/B7 Deficiency Attenuates Systolic Overload-Induced Congestive Heart Failure, Myocardial and Pulmonary Inflammation, and Activated T Cell Accumulation in the Heart and Lungs.Experimental and Human Evidence for Lipocalin-2 (Neutrophil Gelatinase-Associated Lipocalin [NGAL]) in the Development of Cardiac Hypertrophy and heart failure.Vinpocetine Attenuates Pathological Cardiac Remodeling by Inhibiting Cardiac Hypertrophy and Fibrosis.Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis.A tail of translational regulation.Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats.The association between annexin A5 (ANXA5) gene polymorphism and left ventricular hypertrophy (LVH) in Chinese endogenous hypertension patients.The pathological role of vascular aging in cardio-metabolic disorder.Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.Immunity, Inflammation, and Oxidative Stress in Heart Failure: Emerging Molecular Targets.Pregestational type 2 diabetes mellitus induces cardiac hypertrophy in the murine embryo through cardiac remodeling and fibrosis.An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress.Immunotherapy for cardiovascular disease.Preparation of viable adult ventricular myocardial slices from large and small mammals.New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases.Immune mechanisms in heart failure.MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.Vascular Senescence in Cardiovascular and Metabolic Diseases.Paracrine Effects of FGF23 on the Heart.Therapeutic Potential of Polyphenols in Cardiac Fibrosis.Nox2 in regulatory T cells promotes angiotensin II-induced cardiovascular remodeling.Inflammation in Right Ventricular Failure: Does It Matter?Cardiac fibrosis: new insights into the pathogenesisHeterocellularity and Cellular Cross-Talk in the Cardiovascular System
P2860
Q26781720-B3E11C13-ED29-4769-81E4-689F7D882357Q33877795-BA57202E-E01C-455D-BB75-9588AFE41166Q36437116-2B4964B6-7852-4CB0-959A-89BC182E6D1AQ36479405-62A7C2D9-4863-4E07-B522-B0140E0A0C7AQ36552350-B9A6709C-DD14-4C2C-96C5-CAE8CFF0D506Q36842050-824528D6-8671-4D60-AA3E-54D384D2FBCFQ37452461-4D3465BD-8DFF-4BFF-B3DF-CC998B0B9713Q37741735-FF2C7A74-5A9B-41D7-A212-B7F08A42BCD1Q38662968-5F361301-453A-4D8A-8F8C-858862423001Q38850557-5EFA44BF-5470-4BD7-BD60-FBF8DD8CC277Q38872059-A1FB29C6-8B15-419D-9F0F-EF4BE674208DQ38945115-F0032973-8959-4BD1-8BB2-FD2DC38F805DQ39084445-42DCEC5C-2D0C-498D-B89C-BC3E386469FDQ39232014-5427C100-09A4-495A-93BB-0E128B472769Q39255848-246D1B55-63BD-4E8E-81B1-105F61164991Q39285336-E16BC372-9952-44F2-9C40-D282B2C01EE5Q39586569-D38C745F-A857-4ED4-9FC9-CDA77EA5F394Q40159826-3DCD2CCF-80B8-447F-A033-C5D315FD7346Q40286859-59994EFA-7499-4718-9640-BD18932D2CC8Q40715496-C4545091-0BCB-41B6-8282-6DD80008EF69Q41026763-B58CB2C4-F9ED-4BEA-A2F3-5B7AF99C3567Q43375903-8C695CE0-63EA-4F88-BE4B-C8EED15F0CF8Q47122683-1470CDCC-864C-4006-84E3-C47FF8B58C4BQ47146555-F282AF09-88D3-49C4-A169-7702B87CF760Q47699621-87D4DAC5-AED8-47FF-95C9-D6F6BBA88BBEQ47756011-30518DB8-E231-481D-B86E-D2476B3E8FADQ47793229-1C5876CD-F739-4EFF-96A6-FEF5F4A20052Q48254541-DA1C4244-9262-44E7-A818-B1DF3F5BD8F7Q48532758-8A914BF2-CD70-4F9B-A37C-153AFB478EE4Q49491883-DBCC2FA9-A3A2-4D15-A765-389A779359D7Q49531175-8BBBE43C-09E7-41F6-9582-E420C90FBD83Q50168083-06C3C892-3DDF-420F-90B8-00DEE8F0E5CDQ50990734-7CB91A9D-B668-4060-AFCF-F81243FD89F1Q51761509-6F380AF0-004E-4B59-9F4E-47A23142F6AAQ55221465-55650206-FE31-40E1-A106-0D9AA0F78425Q55289622-B65E4BE0-BDC1-44B6-A01D-3BA5ED4A57DEQ55712496-D3F0FE6B-E3F8-4515-A89F-019660DF467FQ58735426-6FC5BF57-4960-4066-BE14-68610F9BC143Q58757982-0221442A-E997-4172-8603-F71FC92D1D64Q59133004-D6F26C68-932F-4FFF-B896-F4EEC03A6DFF
P2860
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
@en
type
label
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
@en
prefLabel
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
@en
P2860
P1433
P1476
Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling.
@en
P2093
Richard M Mortensen
Ryan A Frieler
P2860
P304
P356
10.1161/CIRCULATIONAHA.114.008788
P407
P577
2015-03-01T00:00:00Z